Recurrence Risk Based on Pathologic Stage After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Implications for Risk-Based Postoperative Surveillance Strategies

Sha Zhou,Shiliang Liu,Li Zhang,Suping Guo,Jingxian Shen,Qiaoqiao Li,Hong Yang,Yanfen Feng,M. Liu,Steven Hsesheng Lin,Mian Xi

Recurrence Risk Based on Pathologic Stage After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Implications for Risk-Based Postoperative Surveillance Strategies

2018

Sha Zhou
Shiliang Liu
Li Zhang
Suping Guo
Jingxian Shen
Qiaoqiao Li
Hong Yang
Yanfen Feng
M. Liu
Steven Hsesheng Lin
Mian Xi

Background This study aimed to investigate the association between pathologic stage and recurrence risk and survival for patients with esophageal squamous cell carcinoma (SCC) after neoadjuvant chemoradiotherapy (CRT).

Keywords:

Pathologic stage
Carcinoma
Cell
Pathology
Oncology
Chemoradiotherapy
Medicine
Internal medicine
recurrence risk
Survival rate
neoadjuvant chemoradiotherapy
Gastroenterology
esophageal squamous cell carcinoma
Surgical oncology
General surgery
Disease
Esophagectomy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations